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Abstract 
 
Background 
 The use of cheaper generic medicines is a strategy promoted 
in many countries to reduce rising health care costs.  The aim 
of this study was to explore factors affecting generic medicine 
prescribing by physicians in Basrah, Iraq. 
Methodology 
 A purposive sample of ten physicians practicing in Basrah 
was interviewed using a semi-structured interview guide. 
Results 
 Analysis  of  the  interviews  identified  seven  major  themes: 
medicine  prescribing  practice,  knowledge  of  therapeutic 
equivalency  of  generic  medicine,  patients’  acceptance  of 
generic  medicine,  counterfeit  medicine,  drug  information 
source  and  effect  of  drug  advertising  on  medicines  choice, 
brand substitution practice by community pharmacists, and, 
finally  strategies  to  improve  generic  medicine  usefulness. 
Participants  identified  helpful  strategies  to  increase  generic 
prescribing  including;  physician  and  patient  education  on 
generic medicine; persuading physicians about the safety and 
efficacy  of  generic  medicines;  and  finally  educating  senior 
medical students on generic prescribing. 
Conclusion 
 The  data  suggest  that  participants  were  enthusiastic 
about prescribing generic medicines. However physicians 
insist  that  pharmacists  should  not  be  allowed  to 
substitute  generic  drugs  without  prior  approval  of 
doctors. 
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Introduction  
In Iraq, the Ministry of Health (MOH) is responsible for 
importing medicines from companies that are previously 
registered  with  KIMADIA  (the  state  company  for 
importation  and  distribution  of  drugs  and  medical 
appliances).    The  MOH  distributes  imported 
pharmaceuticals to the public and private sectors (private 
pharmacies)  after  obtaining  permission  from  the  Drug 
National Quality Control Laboratories (DNQCL). 
 
Iraqi  law  requires  all  drugs  to  be  marketed  via  the 
KIMADIA system. For over 20 years, KIMADIA has been 
the  sole  body  authorised  to  carry  out  management, 
planning, selection, quantification, procurement, storage 
and distribution of medicines and medical equipment.   
 
In  1989,  it  was  estimated  that  70%  of  drugs  were 
imported.  The  other  30%  came  from  Samara  Drugs 
Industries  (SDI),  a  government  agency.
1  Until  1994;  the 
supply of medicines was dominated by the public sector. 
Approximately 90% of the drugs purchased using public 
funding was allocated to the public sector.  
 
Currently, there is no social health insurance system exist 
in  Iraq.  There  are  very  small,  isolated  health  insurance 
programs  for  employees  of  specific  companies.  At 
present, however, there is no system for reimbursement 
for money spent by public on private prescriptions in the 
country.
2  Thus,  ensuring  the  availability  of  high-quality 
drugs at affordable prices in Iraq is a public health priority. 
 
Prescribing  drugs  by  generic  name  and  encouraging 
pharmacists  to  dispense  prescriptions  with  generic 
medicines  is  one  frequently  suggested  means  for 
lowering the costs of healthcare.
3-5 Various articles have 
discussed  the  implications  of  generic  substitution  and 
other strategies to reduce pharmaceutical expenditure.
6-
9  The  concept  of  prescribing,  dispensing  and  using 
generic  medicines  has  been  controversial, 
however.
5Concern  has  been  expressed  by  physicians 
practicing  elsewhere  about  the  efficacy  of  generic 
medication.
10,11This  debate  has  centered  on  issues 
related to bioequivalence and potential confusion that 
might arise when changes of medicine brands occur in 
some patient populations.
12,7 The theoretical framework 
for this study calls on bounded rationality theory which 
predicts that the quality of the decisions we make are 
limited  by  the  available  information  and  our  ability  to 
synthesize that information.
13  
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Previous  study  had  shown  that  the  decision  to  prescribe  a 
generic medicine as opposed to its innovator competitor is 
complex.
11 Although prescribing of generic drugs is considered 
good  practice  and  is  encouraged  from  an  educational  and 
cost-effectiveness point of view, the rate of generic medicine 
is still low which might be due to exposure to promotional 
activities by drug companies.
3,5  
 
To  the  best  of  our  knowledge,  no  studies  are  currently 
published reporting physicians’ attitudes to generic medicines 
in  Iraq.  Although  a  few  studies  have  been  conducted  in 
developed  countries  such  the  United  Kingdom,  the  United 
States and Australia, it is very difficult to extrapolate these 
results  to  the  Iraqi  context  because  those  countries  have 
distinct healthcare, and economic systems. Therefore, the aim 
of  this  study  was  to  explore  perceptions  held  by  Iraqi 
physicians towards the use of generic medicines. 
 
Method 
Since little research has been carried out in Iraq to identify 
physicians’  perceptions  of  generic  medicines,  qualitative 
methods were used to gain understanding of this issue.
14,15A 
qualitative approach was adopted because it allows a flexible 
exploration  of  informants'  attitudes  and  experiences  and 
produces a richness of data that allows the researcher to gain 
a deeper understanding of social phenomena.
, 16,17 
 
One of the challenges faced in the process of recruitment was 
to obtain a varied sample of informants to participate in the 
interviews. To address this, purposive sampling procedure was 
used.  The  advantages  of  purposive  sampling  are  that  it  is 
cheaper and time-saving to implement in comparison to other 
sampling  procedure.  Semi-structured  interviews  were 
conducted with a convenient sample of physicians until we 
reached saturation of themes.
  18,  19 The interview guide was 
developed following an extensive review of the literature on 
similar  studies  conducted  elsewhere.  Physicians  were 
approached  personally  by  the  researcher  at  their  college, 
hospital  or  private  clinic.  Those  who  agreed  to  participate 
were interviewed either at once or after all of that physician’s 
patients in the hospital or clinic had been examined.  
 
Ten physicians consented to be interviewed. The interviews 
covered the following issues: medication prescribing priorities, 
knowledge and confidence with generic medicine and brand 
substitution by community pharmacists. Follow-up questions 
were used when necessary to get a more in-depth explanation 
and to draw out more complete ideas from the participants. 
They were given freedom to express additional views on the 
subject at the end of the interview time.
20  
 
All  interviews  were  conducted  at  the  convenience  of  the 
participants:  five  at  the  physician’s  private  clinic,  two  in  a 
hospital and three in the College of Medicine at University of 
Basrah.  Interviews  took  an average  of  20-30  minutes.  They 
were  conducted  by  the  investigator  in  his  native  language 
(Arabic).  Interviews  were  documented  and  transcribed 
verbatim by qualified transcribers. Transcripts were confirmed 
by the researcher, corrections (if needed) were made before 
copies  of  the  transcripts  were  sent  to  the  respective 
physicians  for  their  endorsement.  The  researcher  manually 
analysed  all  of  the  transcripts  line-by-line  for  relevant 
content and themes.
 21,22 Ten interviews were required to 
achieve  saturation  of  the  themes,  and  no  new  themes 
emerged in the last three interviews. 
 
Results 
 
Characteristics of participants 
Ten  physicians  from  various  group  practices  were 
interviewed. Eight of them were practicing in the central 
city  and  the  other  two  in  rural  regions  in  Basrah. 
Demographic  characteristics  were  summarized  in  the 
Table 1. 
 
Themes 
Thematic  content  analysis  of  the  interviews  identified 
seven  major  themes:  medicine  prescribing  practices, 
knowledge  of  therapeutic  equivalency  of  generic 
medicines,  patients’  acceptance  of  generic  medicines, 
counterfeit medicines, sources of drug, and the effect of 
drug  advertising  on  pharmaceutical  selection,  brand 
substitution  practices  by  community  pharmacists,  and 
strategies to improve the usefulness of generic medicines. 
 
Theme 1:  Medicine prescribing practice: 
Physicians were questioned about the factors they took 
into consideration when prescribing a medicine to their 
patients. The major factors identified were availability of 
the  drug  in  hospitals  and  pharmacies,  cost  of  the 
medicine,  safety  and  quality  profile  of  the  medicine 
(reputation of the company supplying the drug), economic 
situation of the patient and severity of the disease. 
 
"Well, availability of drugs in pharmacies or hospitals is 
the most important factor for the time being” (Phy.0 1)   
 
 "The price of medicine is the most important factor in my 
mind  before  writing  the  prescription,  if  the  price  is 
suitable, I will favour it" (Phy.07) 
 
"A  company's  reputation  is  of  the  highest  importance; 
prescribing  a  medicine  from  an  unknown  company 
(possibly not good quality) can lead to financial loss for 
the patients in addition to therapeutic failure"(Phy0.2) 
 
When  physicians  were  asked  whether  they  prescribed 
generic  medicine,  there  were  mixed  reactions.    Some 
physicians  were  against  prescribing  generic  medicines, 
whereas  others  were  more  open  minded.  The  most 
commonly  cited  reasons  for  opposing  generic  medicine 
are  the  potential  clinical  problems  (therapeutic  failure 
and/or allergy). 
 
“I don’t prescribe generic medicine because I do not have 
confidence  in  the  therapeutic  effect  of  this  type  of 
medicine” (Phy.02)  
 
Patient  confusion  also  mentioned  as  a  factor  that 
prevents physicians from prescribing generic medicines. 
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"I  don’t  prescribe  generic  medicine  because  it  can  lead  to 
patients`  confusion,  particularly  among  the  elderly  people" 
(Phy. 03) 
 
The physicians noted that the quality and efficacy of generic 
drugs deter them from prescribing generic medicines. Some 
physicians and their patients believe that generic medicines 
differ  from  the  innovative-brand  in  terms  of  quality  and 
safety,  and  this  prevents  them  from  prescribing  generic 
medicines to their patients. 
 
"Patients may have worries that generic medicine could lead 
to deterioration of their condition rather than improving it" 
(Phy. 10) 
 
In  order  to  prevent  substitution  of  the  medicines  in  the 
pharmacy, physicians said that they write trade names and do 
not use generic names in their prescriptions. 
 
"I write trade names to prevent the substitution in the 
pharmacy and to stop them from giving any medicine that 
does not work" (Phy.03) 
 
Disease  severity  is  a  factor  that  inhibits  physicians  from 
prescribing generic medicines. In severe cases, physicians tend 
to use innovative medicines. 
 
“In  chronic  cases,  I  don’t  prescribe  any  generic  medicine” 
(Phy.10) 
 
Physicians  who  encourage  generic  medicines  prescribing 
report that the low price of generic medicines as the most 
common incentive for prescribing generic medicines. 
 
"Cost of medicine is of the highest importance, especially to 
patients  on  low  income,  generic  medicine  is  an  inexpensive 
medicine, and therefore I prescribe generic medicine"  (Phy.01)  
 
The  availability  of  differently-priced  alternatives  for  the 
product is a motive for prescribing generic medicines. 
 
"It is not fair to write a medicine for example, Daonil® and the 
price for this drug is about 25000 ID (USD $  20 for 20 tablets) 
while I can give him the same medication with the same 
efficacy with price 1200 ID (USD $ 1  for 20 tablets)" (Phy.08) 
 
Theme 2: Knowledge of therapeutic equivalency of generic 
medicine 
Physicians were questioned about the bioequivalence criteria 
required  by  the  World  Health  Organization  (WHO)  and/or 
Food  and  Drug  Administration  (FDA)  and  the  KIMADIA  and 
DNQCL  in  Iraq.  We  found  that  physicians  had  little  or  no 
knowledge about these requirements. 
 
"I don’t really need this information because I don’t prescribe 
them" (Phy.2)   
 
Theme 3: Patients acceptance of generic medicines 
All of the physicians who prescribe generic medicines felt that 
their patients are amenable to using these drugs. The main 
reason  the  physicians  believe  that  their  patients  accept 
generics is due to low socioeconomic status, meaning that 
these  patients  often  cannot  afford  the  high  prices  of 
innovative medicine. 
  
"Yes,  the  patients  regularly  ask  me  to  prescribe  cheap 
medicine and if I am satisfied with the generic medicine it 
is easy to convince the patient" (Phy.01)   
 
Some physicians thought that patients' trust in physicians 
is important for accepting generic medicines. 
 
"The physicians' confidence in generic medicine positively 
reflects on the patient"(Phy. 03)  
 
Theme 4:  Counterfeit medicine 
All  of  the  physicians  agreed  that  there  are  a  lot  of 
counterfeit drugs in Iraq, and they hope that the NDQCL 
and MOH can eliminate this problem. 
 
"There are a lot of counterfeit medicines currently so we 
must reduce this problem by having a powerful control on 
pharmaceutical medicine allowed in Iraq" (Phy.02)  
 
"I  cannot  make  a  distinction  between  counterfeit  drugs 
and regular drugs. Counterfeiting is an elaborate process 
and this must be countered by the regulatory and quality 
control processes" (Phy.04) 
 
Theme 5: Drug information sources and influence of drug 
advertising on medicine choice 
Physicians were asked about the information sources they 
used in order to update themselves about medicines. The 
main  sources  were  textbooks,  pharmaceutical  industry 
representatives, the Internet, leaflets, and pharmacists. 
 
"Textbooks, I have a book called ' MARTINDALE' where I 
can look for everything about the medicine" (Phy.08) 
 
"BNF,  Iraqi  Drug  Guide,  pharmaceutical  industry 
representative and the Internet" (Phy.10) 
 
All physicians who encourage the use of generic medicine 
agreed that advertising positively influenced their choice 
of generic drugs. 
 
"Sure,  all  companies  seeking  to  advertise  the  new 
medicines through the medical conferences or distribute a 
free medical sample to the physicians"(Phy.07) 
 
"Exactly, gifts from companies' give great motivation to 
encourage  doctors  to  use  these  medicines  from  their 
companies" (Phy. 05) 
 
Theme  6:  Brand  substitution  practices  by  community 
pharmacists 
Brand  substitution  refers  to  the  substitution  of  a  drug 
with  another  medication  without  permission  from  the 
prescriber. Most physicians are unhappy with the current 
practice of brand substitution by pharmacists.  
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"This is a problem, when I prescribe innovative medicines for 
my patient and sometime if the patient  
came back with generic medicines, I don't agree with these 
substitutions" (Phy.03)  
 
The main reasons mentioned by physicians to refuse brand 
substitution  are  interfering  with  the  physician's  choice  of  a 
certain brand, inadequate training of the pharmacy staff, and 
fear of therapeutic failure of the substitute. 
 
Some of the physicians generally support generic substitution, 
but  they  note  that  there  are  some  cases  where  it  is  not 
appropriate.  
 
"Agreed,  but  not  in  all  cases,  not  in  low  therapeutic  index 
drugs" (Phy.04) 
 
"I am in agreement, but due to the multi-source medicines in 
pharmacies, they must consult a doctor to change specifically 
in chronic diseases" (Phy.01) 
 
All physicians felt that if the alternative brand is of a good 
quality  and  if  the  decision-maker  is  a  knowledgeable 
pharmacist, he should be able to do brand substitution. 
 
Theme 7:  Strategies to improve generic medicine utility 
All the physicians who encourage the use of generic medicines 
said  that  a  greater  physician  education  about  generic 
medicine could increase prescriptions for these medications 
and positively impact patients’ perceptions on their use. 
 
 "Increase physician education regarding safety and quality of 
generic  medicine  through  conferences  or  presentations,  this 
will lead to an increase in prescribing generic medicine" (Phy. 
01) 
 
"Increase the doctors’ and patients’ awareness about generic 
medicine by the sending out on a quarterly basis a drug guide, 
with listings of legal drugs. This will lead to an increase usage 
of generic medicine" (Phy.3) 
 
One  way  to  improve  prescribing  practices  is  to  review  the 
medical  curriculum  in  Iraqi  universities  and  add  topics 
regarding generic medicine and cost effective prescribing and 
dispensing  techniques.  This  would  encourage  the  use  of 
generic medicines in the future. 
 
"I strongly support the idea to develop curriculum for students 
of the Faculty of Medicine regarding generic medicines and 
how they should compare generic medicines with the original 
medicines" (Phy.0 7) 
 
Discussion 
As  the  main  prescribers  of  medicines  in  Iraqi  healthcare 
facilities and institutions, physicians have an important role in 
the  utilisation  of  generic  medicines.  This  exploratory  study 
offer  some  insights  into  the  perceptions  of  physicians 
regarding  the  use  of  generic  medicines.  In  this  qualitative 
study, physicians reported that availability of the drug in Iraqi 
markets  plays  an  important  role  in  prescribing  decisions.  
Beside  therapeutic  efficacy,  factors  such  as  cost  of  the 
prescribed  medications  were  also  considered  to  be  the 
most important factors in choosing a medication. In Iraq, 
at present, there is no health insurance and the patient 
must pay for physician fees and they also have to pay the 
cost of medications prescribed. This payment scheme for 
health services and prescribed medicines makes patients 
and physicians more sensitive to the value of services and 
goods rendered.  
 
The  analysis  of  the  interviews  also  highlight  potential 
barriers to using generic  medicines.  Two major barriers 
identified  were  the  potential  for  confusion  among 
patients and the physician’s  belief that generics are not 
equivalent  to  branded  counterparts.  These  reasons  are 
similar to those reported in previous studies in Australia 
that  focused  on  general  practitioners’  beliefs  about 
generic  substitutions.
  23,24  Beliefs  about  the  decreased 
quality of generics could be dispelled by better physician 
education  regarding  drug  discovery,  development,  and 
registration regulations.  
 
None  of  the  physicians  interviewed  in  this  study 
recognised  the  bioequivalence  acceptability  criteria  for 
generic medicines as set by the World Health Organisation 
(WHO) and followed by NDQCL.
25 Their lack of knowledge 
could have a negative impression on the future of generic 
prescribing.  Product  quality  data  required  before  a 
generic  product  can  be  registered  by  KIMADIA  and 
marketed to Iraqi consumers. The required quality data 
includes:  purity,  stability,  Good  Manufacturing  Practice 
(GMP) and quality control.
26-28 these details are the same 
for  all  products,  generic  or  innovative-brand,  that  seek 
approval for sale in Iraq.
29 
 
On the issue of patients’ acceptance of generic medicines, 
our  study  found  that  nearly  all  physicians  felt  their 
patients had good acceptance rate to generic medicines.  
 
In this study, all of the physicians were dissatisfied with 
the increase in counterfeit drugs in Iraq.  They all depend 
on KIMADIA and NDQCL to solve this problem and prevent 
distribution and usage of these drugs.  Improving facilities 
at the laboratories of KIMADIA and NDQCL would be a 
logical next step to solve this problem. 
Physicians' opinions on the influence of drug advertising 
and incentives on their choice of medicine brands were 
also explored in this study. Advertising strategies used by 
drug  companies  can  influence  the  brand  of  drug  a 
physician prescribes. These qualitative results are similar 
to two other studies,  which found that incentives from 
pharmaceutical  companies  led  to  increased  prescribing 
rates of the products.
,30,31  
 
The  majority  of  physicians  were  dissatisfied  with  the 
practice  of  generic  substitution  by  community 
pharmacists  without  previous  agreement  from  the 
prescriber.  Their main reason for this dissatisfaction is a 
lack of formal guidelines on how many times a pharmacist 
can change the patients' medication brand.  In the long 
term, multiple changes in a patient’s medication can lead 
to  confusion  and  possible  inappropriate  dosing.  The  Australasian Medical Journal 2009, 1, 8, 58-64 
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physicians  also  expressed  concern  that  those  who  perform 
substitutions  are  pharmacy  staff  who  are  not  qualified  to 
make these decisions. 
 
Physicians  who  were  comfortable  with  prescribing  generic 
medicines  suggested  that  to  improve  the  use  of  generic 
medicines, physicians need to be educated about the quality 
and  efficacy  of  generic  medicines.  Furthermore,  generic 
medicine  guidelines  which  include  all  generic  medicines 
available in Iraq should be distributed to the physicians via 
KIMADIA  or  Association  of  Medical  in  Iraq  so  that  the 
physicians  feel  more  confident  and  this  would  lead  to  an 
increase  in  generic  medicine  prescribing.  Finally,  a  few 
physicians  suggested  that  one  way  to  increase  future 
acceptance and prescribing of generic  medicines is to educate 
senior medical students about cost effective prescribing which 
is not currently  taught in Iraqi medical curricula.
 
 
Study Limitations  
One of the limitation of qualitative methods is that the results 
cannot be extrapolated to the wider popualtion.
32This study 
was conducted in Basrah city in Iraq and the findings may not 
apply  to  physicians  living  in  other  governorates  in  Iraq. 
However, as the prescribing process for medications in Iraq is 
the same, it is likely that physicians from other parts of the 
country  will  have  similar  views  on  the  issues  explored.  We 
were  unable  to  include  physicians  from  other  governorates 
due to limited funding.  
 
Conclusion 
Prescribing  generic  medicines  requires  a  complex  decision-
making processes and involves the exercise of personal and 
professional  judgment  about  psychosocial  and  economic 
dimensions of health. This qualitative study of perception of 
physicians  suggests  that  physicians’  enthusiasm  for  generic 
medicines  is  influenced  by  the  high  costs  of  medicines. 
Unfortunately, the prospects of more generic prescribing will 
require  more  education  and  further  reassurance  about  the 
quality, safety and efficacy of generic medicines. A few steps 
have to be taken if generic medicines are to be more widely 
prescribed and dispensed. Firstly, the authority that regulates 
medicines needs to be strengthened so that it can issue strong 
assurance  on  the  quality,  safety  and  efficacy  of  registered 
medicines.  This  could  be  achieved  by  ensuring  sufficient 
manpower, adequate training of staff, and strict enforcement 
of  medicines’  related  registration.  Secondly,  the  image  of 
(KIMADIA and DNQCL) must be improved among physicians, 
pharmacists and patients, so that there is greater confidence 
in  its  ability  to  police  the  safety  and  quality  of  medicines. 
Thirdly,  regulating  pharmaceutical  industry  promotion  to 
ensure  compliance  with  internationally  accepted  codes  of 
conduct.  Fourthly  setting  a  suitable  substitution  policy  that 
gives  pharmacists  more  freedom  to  switch  to  dispensing 
generic  products  but  only  after  dealing  with  the  other 
challenges mentioned above.  
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Table 1   : Participants demographics (N = 10) 
 
Descriptions  n 
Age range: 
30-40 
40-50 
51-60 
 
2 
7 
1 
Gender: 
Male 
Female 
 
8 
2 
Place of graduation: 
Baghdad university 
Basrah university 
 
3 
7 
Number of prescriptions written per day: 
Less than 15 
More than 15 
 
4 
6 
Number of years practicing in Iraq: 
Under 15 
More than 15 
 
2 
8 
Place of work 
Government hospital 
Private hospital 
 
9 
1 
 
 
 
 
 
 